Three years ago, families of patients who relied on medical cannabis to manage severe illnesses celebrated when Georgia lawmakers signed off on local production of low-THC oil.
But the promised path to relief has been marred by a clumsy licensing system – one that faces challenges in court – and lawmakers are under pressure to fix the situation.
Georgia’s medical marijuana board – the Georgia Access to Medical Cannabis Commission – granted licenses to six companies out of 69 applicants last year. Speculation swirled over the legitimacy of the bidding system after the final companies were approved and 22 failed applicants filed protests – halting any progress on launching the industry.
One cannabis company, Georgia Atlas, even filed a lawsuit alleging the licensing process was “lacking in transparency, objectivity and fairness.”
During a commission meeting over the weekend, Andrew Turnage, the executive director of the state board, said the protest process is on track to be completed this year, which would finalize the granted licenses.
